Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Dynamics of hepatitis C epidemic among people living with HIV in Estonia based on Estonian HIV cohort study

Fig. 2

The flow chart of study populations in the Estonian HIV Cohort Study (E-HIV) between 2000 and 2015. The study population included 4422 HIV positive subjects of 5439 patients linked to the care. Of latter, 84% (3708/4422) had information about their HCV serostatus; 61% (2706/4422) were HCV seropositive, 23% (1002/4422) HCV seronegative and 16% (714 /4422) patients had no information about their HCV status. Of HCV seropositive subjects 60% (1625/2706) were HCV RNA positive, 9% (239/2706) had their HCV GT determined and 5% (141/2706) were treated for HCV

Back to article page